SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMF)
Clinical trial NCT06447597 updates: 1. completion date: 2026-06-30 → 2026-12-30 2. primary completion date: 2026-06-30 → 2026-12-30
Clinical trial NCT06447597 updates: 1. completion date: 2026-06-30 → 2026-12-30 2. primary completion date: 2026-06-30 → 2026-12-30
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical